Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence
Authors:
- Renata A TassiRTRenata A Tassi
- Stefano CalzaSCStefano Calza
- Antonella RavaggiARAntonella Ravaggi
- Eliana BignottiEBEliana Bignotti
- Franco E OdicinoFOFranco E Odicino
- Germana TognonGTGermana Tognon
- Carla DonzelliCDCarla Donzelli
- Marcella FalchettiMFMarcella Falchetti
- Elisa RossiERElisa Rossi
- Paola TodeschiniPTPaola Todeschini
- Chiara RomaniCRChiara Romani
- Elisabetta BandieraEBElisabetta Bandiera
Open Access
- 27 July 2009
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 9 (1) , 253
Abstract
Traditional prognostic factors in epithelial ovarian cancer (EOC) are inadequate in predicting recurrence and long-term prognosis, but genome-wide cancer research has recently provided multiple potentially useful biomarkers. The gene codifying for Mammaglobin B (MGB-2) has been selected from our previous microarray analysis performed on 19 serous papillary epithelial ovarian cancers and its expression has been further investigated on multiple histological subtypes, both at mRNA and protein level. Since, to date, there is no information available on the prognostic significance of MGB-2 expression in cancer, the aim of this study was to determine its prognostic potential on survival in a large cohort of well-characterized EOC patients.Keywords
This publication has 33 references indexed in Scilit:
- Mammaglobin B expression in human endometrial cancerInternational Journal of Gynecological Cancer, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Variable selection under multiple imputation using the bootstrap in a prognostic studyBMC Medical Research Methodology, 2007
- Molecular predictors of response and outcome in ovarian cancerCritical Reviews in Oncology/Hematology, 2006
- RT-PCR for Mammaglobin Genes, MGB1 and MGB2, Identifies Breast Cancer Micrometastases in Sentinel Lymph NodesAmerican Journal of Clinical Pathology, 2004
- Mammaglobin Is Associated With Low-Grade, Steroid Receptor-Positive Breast Tumors From Postmenopausal Patients, and Has Independent Prognostic Value for Relapse-Free Survival TimeJournal of Clinical Oncology, 2004
- Combination of Cytology, Fluorescence In Situ Hybridization for Aneuploidy, and Reverse-Transcriptase Polymerase Chain Reaction for Human Mammaglobin/Mammaglobin B Expression Improves Diagnosis of Malignant EffusionsJournal of Clinical Oncology, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Uteroglobin Expression and Release in the Human EndometriumAnnals of the New York Academy of Sciences, 2000
- Morphometric data to FIGO stage and histological type and grade for prognosis of ovarian tumours.Journal of Clinical Pathology, 1986